These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8813217)

  • 1. Hypokinesia in Huntington's disease.
    van Vugt JP; van Hilten BJ; Roos RA
    Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokinesia in Parkinson's disease: influence of age, disease severity, and disease duration.
    van Hilten JJ; Braat EA; van der Velde EA; Middelkoop HA; van Dijk JG; Lighart GJ; Roos RA
    Mov Disord; 1995 Jul; 10(4):424-32. PubMed ID: 7565821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease.
    van Vugt JP; Siesling S; Piet KK; Zwinderman AH; Middelkoop HA; van Hilten JJ; Roos RA
    Mov Disord; 2001 May; 16(3):481-8. PubMed ID: 11391742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions.
    Carella F; Bressanelli M; Piacentini S; Soliveri P; Geminiani G; Monza D; Albanese A; Girotti F
    Neurol Sci; 2003 Feb; 23(6):287-93. PubMed ID: 12624715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional decline in Huntington's disease.
    Feigin A; Kieburtz K; Bordwell K; Como P; Steinberg K; Sotack J; Zimmerman C; Hickey C; Orme C; Shoulson I
    Mov Disord; 1995 Mar; 10(2):211-4. PubMed ID: 7753064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of neuropathological severity in 100 patients with Huntington's disease.
    Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
    Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
    van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
    Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease.
    Johnson KA; Cunnington R; Bradshaw JL; Chiu E; Iansek R
    Mov Disord; 2002 Sep; 17(5):998-1003. PubMed ID: 12360549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease.
    Lefaucheur JP; Bachoud-Levi AC; Bourdet C; Grandmougin T; Hantraye P; Cesaro P; Degos JD; Peschanski M; Lisovoski F
    Mov Disord; 2002 Nov; 17(6):1294-301. PubMed ID: 12465071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
    Fenney A; Jog MS; Duval C
    Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of early disability in Huntington's disease.
    Mayeux R; Stern Y; Herman A; Greenbaum L; Fahn S
    Ann Neurol; 1986 Dec; 20(6):727-31. PubMed ID: 2949692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations.
    Whitehead DL; Davies AD; Playfer JR; Turnbull CJ
    Mov Disord; 2008 Jun; 23(8):1137-45. PubMed ID: 18442142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
    Fenney A; Jog MS; Duval C
    Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actigraphic evidence for night-time hyperkinesia in Parkinson's disease.
    Nass A; Nass RD
    Int J Neurosci; 2008 Feb; 118(2):291-310. PubMed ID: 18205084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease.
    Hausdorff JM; Cudkowicz ME; Firtion R; Wei JY; Goldberger AL
    Mov Disord; 1998 May; 13(3):428-37. PubMed ID: 9613733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
    Delval A; Krystkowiak P; Blatt JL; Labyt E; Dujardin K; Destée A; Derambure P; Defebvre L
    J Neurol; 2006 Jan; 253(1):73-80. PubMed ID: 16096818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of the contingent negative variation in Huntington's disease: correlations with clinical features.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    J Neurol Sci; 2007 Mar; 254(1-2):84-9. PubMed ID: 17300807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia.
    Markianos M; Panas M; Kalfakis N; Vassilopoulos D
    Ann Neurol; 2005 Apr; 57(4):520-5. PubMed ID: 15786456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.